HDAC9 and B-cell non-Hodgkin lymphoma: In contrast, low-grade B-cell lymphomas, as well as CHL, showed low HDAC9 expression in tumor cells when nuclear intensity was compared with that of adenocarcinoma cells as a positive control (P=0.004, Fisher's exact test) (Fig. 1C).